What one share of Beone Medicines holds
We are a leading global oncology company discovering and developing innovative treatments that are more accessible to cancer patients worldwide. In 2025, we generated total global revenue of approximately $5.3 billion, increasing revenue by approximately 40.2% from the prior year, while achieving net income of $286.9 million, net cash provided by operating activities of $1.1 billion and positive free cash flow of $941.7 million.
Beone Medicines’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.09 |
|---|---|
| Profit | $0.44 |
| Capex (buildings and equipment) | $0.10 |
| Free cash flow | $0.89 |
| Cash and investments | $3.47 |
| Debt | $0.78 |
| Book value | $3.52 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | — | −$0.18 | $0.01 | −$0.09 | — | −$0.53 |
| 2015 | — | −$0.52 | $0.05 | −$0.41 | — | −$0.88 |
| 2016 | — | −$0.30 | $0.06 | −$0.28 | — | $0.68 |
| 2017 | $0.44 | −$0.17 | $0.09 | −$0.06 | — | $1.13 |
| 2018 | $0.28 | −$0.93 | $0.10 | −$0.86 | — | $2.24 |
| 2019 | $0.55 | −$1.22 | $0.11 | −$1.08 | — | $1.20 |
| 2020 | $0.28 | −$1.50 | $0.11 | −$1.29 | — | $3.25 |
| 2021 | $0.98 | −$1.21 | $0.22 | −$1.29 | — | $4.59 |
| 2022 | $1.06 | −$1.49 | $0.24 | −$1.36 | — | $3.23 |
| 2023 | $1.81 | −$0.65 | $0.41 | −$1.27 | — | $2.60 |
| 2024 | $2.78 | −$0.47 | $0.36 | −$0.46 | — | $2.40 |
| 2025 | $3.62 | $0.19 | $0.13 | $0.64 | — | $3.03 |
Common questions about Beone Medicines
How much does one share of Beone Medicines earn?
Over the last 12 months, each share of Beone Medicines earned $0.44 of profit on $4.09 of sales, keeping about 11¢ of every $1 (profit margin).
Does Beone Medicines pay a dividend?
Beone Medicines didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Beone Medicines’s book value per share?
Beone Medicines’s book value is $3.52 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Beone Medicines have?
Each share of Beone Medicines has $3.47 of cash and investments and $0.78 of debt, as of June 30, 2026.
What is Beone Medicines’s free cash flow per share?
$0.89 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Beone Medicines bought back shares?
Beone Medicines’s share count rose about 1377% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.